Today's episode covers exciting updates from various healthcare and biotech companies. Zynex Inc CEO Thomas Sandgaard discusses the company's growth and future innovations, including FDA approvals for new devices. Syra Health Corp. secures a contract to train healthcare professionals in Indiana, emphasizing health equity principles. Mainz Biomed applies for FDA breakthrough device designation for a promising colorectal cancer test. Global Vision Technologies achieves TX-RAMP Level 2 Certification for their FAMCare Human Services Software. Acarix expands its US market presence with shares now trading on the OTCQB, highlighting growing demand for their CADScor System. Citius Pharmaceuticals nears a market breakthrough with Mino-Lok and LYMPHIR products, while Oncolytics Biotech Inc. works on a promising treatment for pancreatic cancer.